PRMT5 and neuroblastoma: PRMT5 is known to exert epigenetic silencing through histone 3 arginine methylation [7], but our DEGs suggest that epigenetic derepression via PRMT5 inhibition is not a major route of drug action in MNA neuroblastoma.